Trial Profile
Effects of amlodipine/valsartan versus valsartan/hydrochlorothiazide on lipoprotein subfraction profiles in antihypertensive-naive patients with stage 2 or 3 hypertension
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Jan 2012
Price :
$35
*
At a glance
- Drugs Amlodipine/valsartan (Primary) ; Valsartan/hydrochlorothiazide (Primary)
- Indications Hypertension
- Focus Pharmacodynamics
- 10 Jan 2012 New trial record
- 01 Dec 2011 Results published in the Journal of Human Hypertension.